Deepinder Goyal Lashes Out at 'Instagram Doctors' Over Temple Device Criticism

• Zomato CEO Deepinder Goyal responded to criticism regarding his experimental health device, Temple.
• Goyal clarified that Temple is in an experimental stage, with no official commercial announcement or public scientific data.
• He taunted critics for advising against buying a device not yet available for order or pre-order.
• Temple is a sensor device worn on the temple, claiming to monitor real-time brain blood flow based on Goyal's Gravity Ageing Hypothesis.
• Critics, including doctors and neurologists, question the scientific validity and potential for misinformation without clinical validation.

Why It Matters: Deepinder Goyal defends his experimental Temple device, urging patience and scientific validation before judgment.